Johnson & Johnson (JNJ)
154.46
+1.35
(+0.88%)
USD |
NYSE |
Nov 21, 11:28
Johnson & Johnson Price: 154.46 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 153.14 | 153.25 | 151.81 | 153.11 | 7.315M |
Nov 19, 2024 | 153.94 | 153.99 | 152.05 | 153.00 | 8.234M |
Nov 18, 2024 | 152.59 | 155.33 | 152.33 | 154.77 | 7.514M |
Nov 15, 2024 | 150.90 | 154.43 | 150.90 | 154.00 | 11.33M |
Nov 14, 2024 | 153.18 | 153.59 | 150.76 | 151.87 | 7.716M |
Nov 13, 2024 | 152.50 | 153.51 | 151.42 | 153.24 | 7.162M |
Nov 12, 2024 | 154.53 | 155.04 | 152.37 | 152.64 | 7.181M |
Nov 11, 2024 | 155.62 | 157.58 | 154.91 | 155.04 | 7.147M |
Nov 08, 2024 | 157.00 | 157.08 | 155.41 | 155.47 | 8.926M |
Nov 07, 2024 | 158.47 | 158.75 | 156.51 | 156.73 | 7.523M |
Nov 06, 2024 | 159.90 | 160.85 | 157.36 | 157.88 | 8.927M |
Nov 05, 2024 | 157.67 | 158.59 | 156.35 | 158.35 | 6.547M |
Nov 04, 2024 | 159.70 | 160.28 | 158.07 | 158.24 | 4.644M |
Nov 01, 2024 | 160.58 | 161.06 | 159.88 | 160.13 | 5.257M |
Oct 31, 2024 | 159.99 | 160.87 | 159.46 | 159.86 | 8.614M |
Oct 30, 2024 | 159.45 | 161.28 | 159.03 | 160.61 | 5.821M |
Oct 29, 2024 | 161.46 | 162.17 | 160.06 | 160.09 | 5.217M |
Oct 28, 2024 | 161.13 | 161.97 | 161.00 | 161.60 | 4.843M |
Oct 25, 2024 | 163.68 | 163.92 | 160.61 | 160.88 | 6.400M |
Oct 24, 2024 | 165.00 | 165.51 | 163.34 | 163.67 | 5.387M |
Oct 23, 2024 | 162.82 | 166.00 | 162.42 | 165.86 | 7.442M |
Oct 22, 2024 | 162.32 | 163.73 | 161.90 | 163.45 | 5.681M |
Oct 21, 2024 | 165.10 | 165.25 | 162.31 | 162.83 | 6.083M |
Oct 18, 2024 | 164.89 | 165.29 | 163.93 | 165.12 | 5.908M |
Oct 17, 2024 | 164.26 | 165.00 | 163.63 | 164.47 | 4.798M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
111.14
Minimum
Mar 23 2020
186.01
Maximum
Apr 25 2022
159.74
Average
160.68
Median
Sep 05 2023
Price Benchmarks
Amgen Inc | 289.28 |
Eli Lilly and Co | 744.20 |
Merck & Co Inc | 98.25 |
Pfizer Inc | 24.94 |
AbbVie Inc | 170.61 |
Price Related Metrics
PE Ratio | 25.53 |
PS Ratio | 4.276 |
Price to Book Value | 5.301 |
Price to Free Cash Flow | 19.71 |
Earnings Yield | 3.92% |
Market Cap | 371.88B |
Operating PE Ratio | 16.44 |
Normalized PE Ratio | 18.11 |